1. Video
  2. Blasting News France >
  3. Société

Coronavirus : Un espoir de médicament

Title Next Video
Annuler
Voir la vidéo
Lire l'article complet
Des essais cliniques prometteurs pour traiter le Coronavirus
Ne ratez pas les dernières informations
Cliquez sur le sujet qui vous intéresse pour le suivre. Nous vous tiendrons informé des dernières nouvelles à ne pas manquer.
Covid-19
Alors que le monde est en crise sanitaire, plus ou moins en quarantaine ou en confinement, une bonne nouvelle, enfin, vient de tomber. Un médicament, le Plaquenil, pourrait traiter le coronavirus. Cet antipaludique a eu des résultats positifs sur 75% des personnes atteintes du virus. Après six jours de traitement, les patients étaient rétablis. L’heure n’est pas encore aux applaudissements, rien n’est encore fait, mais dans le climat actuel, cela met du baume au cœur.
Covid-19
Blasting News travaille avec l’Union européenne dans la lutte contre les fausses informations.
We use cookies and similar tracking technologies to provide you with a personalized service based on your browsing needs and to analyze our traffic. We collect and share with our 1545 partners who deal with web data analysis, advertising, and social media, some information about your device, such as IP address and device characteristics, which they may combine with other information you have provided them or collected from your use of their services. You can consent to the use of such technologies by clicking the "Accept All" button on this banner or customize your choices, possibly denying consent to the processing of personal data by third-party partners by clicking the "Customize" button.
By closing this banner (clicking the "X" button in the top right corner), you consent to the persistence of default settings that do not allow the use of cookies or other tracking tools other than technical ones.
We and our partners process your browsing data to: store and/or access information on a device; use limited data for ad selection; create profiles for personalized advertising; use profiles to select personalized advertising content; measure the performance of advertising; measure the performance of content; understand the audience through statistical combinations of data from different sources; develop and improve services; use limited data to select content.
To learn in detail which cookies we use on the site and to change your preferences at any time, we invite you to consult our Cookie Policy.
Retour
More information
By accepting "all cookies", including profiling cookies, in addition to supporting our free offer, you will receive advertisements in line with your interests.
On the other hand, by clicking only on “accept strictly necessary cookies”, you will receive non-targeted advertising whose number and repetition will not be limited.